Lung Cancer News

Proton FLASH radiotherapy showed clinical feasibility in a first-in-human study of patients with cancer and painful bone metastases, according to data presented at American Society for Radiation Oncology Annual Meeting.

GENEVA — Lower BMI may increase risk for lung cancer, according to results of an ongoing prospective study presented at World Cancer Congress.

A fourth dose of the COVID-19 vaccine increased humoral immunity among patients with solid and hematologic cancers, according to study results published in JAMA Oncology.

NASHVILLE, Tenn. — Shape-sensing robotic-assisted bronchoscopy with cone-beam CT imaging showed promise for diagnosing central, distal-airway and peripheral pulmonary lesions in a single-center study presented at the CHEST Annual Meeting.

High-dose dexamethasone failed to improve shortness of breath compared with placebo among ambulatory patients with cancer, according to study results published in The Lancet Oncology.

The presence of non-cystic fibrosis bronchiectasis increased risk for lung cancer regardless of smoking status, according to recent findings published in Annals of the American Thoracic Society.

Parker Institute for Cancer Immunotherapy added Dana-Farber Cancer Institute and Gladstone Institutes to its immuno-oncology research partnership network.

Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology researchers.

A head-to-head trial of the PD-1 inhibitors dostarlimab and pembrolizumab, each in combination with chemotherapy, met its primary endpoint of objective response rate among patients with metastatic nonsquamous non-small cell lung cancer.

Immune checkpoint inhibitors had a favorable impact on patient-reported quality-of-life compared with other standard therapies across a variety of advanced solid tumor types, data from a meta-analysis showed.